Trial Profile
Effect of Dexmedetomidine Infusion for Postoperative Outcome and Smooth Emergence After Thyroidectomy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2020
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Desflurane; Remifentanil
- Indications Postoperative complications
- Focus Therapeutic Use
- 25 Nov 2020 Status changed from recruiting to completed.
- 02 Mar 2020 Planned End Date changed from 30 Apr 2020 to 30 Apr 2021.
- 02 Mar 2020 Planned primary completion date changed from 30 Apr 2020 to 30 Dec 2020.